Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)
- Conditions
- Anemia, Sickle Cell
- Registration Number
- NCT03380351
- Lead Sponsor
- Washington University School of Medicine
- Brief Summary
The goal of this study is to specify the interventions, implementation strategies and control conditions from the Sickle Cell Disease Implementation Consortium (SCDIC) using a mixed-methods approach to study site materials and conduct semi-structured qualitative interviews with site representatives (N=3 per site). We focused on the Emergency Department Working Group from the SCDIC working groups.
- Detailed Description
The long-term goal of this line of research is to identify the most effective components of SCD interventions while also identifying effective implementation strategies informed by a systematic and rigorous work done by the members of the SCDIC consortium to improve the quality of life of people with SCD, a life-threatening hematological disorder. This study aims to collect detailed information about the planned interventions, the implementation strategies and the control conditions from each site.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 17
- three representatives of each of the SDIC sites: the Principal Investigator, and two people nominated by the PI.
- none
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SCDIC Framework of Interventions 2 years Detailed descriptions of the interventions being developed by the SCDIC including a) entity, or entities, targeted by the intervention; (b) functional domains targeted by the interventions; and (c) delivery system characteristics
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Washington University in St. Louis
🇺🇸Saint Louis, Missouri, United States
Washington University in St. Louis🇺🇸Saint Louis, Missouri, United States